Comparison of treatment options in adults with frequently relapsing or steroid-dependent minimal change disease

HEYBELİ C., Erickson S. B., Fervenza F. C., Hogan M. C., Zand L., Leung N.

NEPHROLOGY DIALYSIS TRANSPLANTATION, vol.36, no.10, pp.1821-1827, 2021 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 10
  • Publication Date: 2021
  • Doi Number: 10.1093/ndt/gfaa133
  • Journal Name: NEPHROLOGY DIALYSIS TRANSPLANTATION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.1821-1827
  • Keywords: calcineurin inhibitors, cyclophosphamide, minimal change disease, mycophenolate mofetil, rituximab, CHANGE NEPHROTIC SYNDROME, MYCOPHENOLATE-MOFETIL, PREDNISOLONE THERAPY, RITUXIMAB TREATMENT, CHANGE NEPHROPATHY, OPEN-LABEL, ONSET, TACROLIMUS, CHILDREN, MULTICENTER
  • Dokuz Eylül University Affiliated: Yes

Abstract

Background. Studies comparing all treatment options for frequently-relapsing/steroid-dependent (FR/SD) minimal change disease (MCD) in adults are lacking.